Skip to main navigation Skip to search Skip to main content

Quetiapine albumin nanoparticles as an efficacious platform for brain deposition and potentially improved antipsychotic activity

  • Hend Mohamed Abdel-Bar
  • , Alaa S. Tulbah
  • , Hany W. Darwish
  • , Rania Salama
  • , Ibrahim A. Naguib
  • , Heba A. Yassin
  • , Hadel A. Abo El-Enin

Research output: Contribution to journal › Article › peer-review

87 Downloads (Pure)

Abstract

Quetiapine (QP) is a second-generation short-acting antipsychotic drug extensively metabolized in the liver, producing pharmacologically inactive metabolites and leading to diminished bioavailability. Therefore, this study aimed to develop an intravenous QP albumin nanoparticles (NPs) system for improving QP antipsychotic activity and brain targeting. QP-loaded albumin NPs were prepared by the desolvation method. The fabricated NPs were characterized in terms of particle size, zeta potential, entrapment efficiency (EE%), and in vitro drug release. In vivo pharmacokinetics and biodistribution in rats were studied. In addition, the antipsychotic activity of the optimized platform was also investigated. Human serum albumin (HSA) concentration, pH, and stirring time were modulated to optimize QP albumin NPs with a particle size of 103.54 ± 2.36 nm and a QP EE% of 96.32 ± 3.98%. In addition, the intravenous administration of QP albumin NPs facilitated QP brain targeting with a 4.9-fold increase in targeting efficiency compared to the oral QP solution. The QP albumin NPs improved the QP antipsychotic activity, indicated by suppressing rats’ hypermobility and reducing the QP’s extrapyramidal side effects. The obtained results proposed that intravenous QP- NPs could improve QP brain targeting and its antipsychotic efficiency.
Original languageEnglish
Article number1785
Pages (from-to)1-16
Number of pages16
JournalPharmaceutics
Volume15
Issue number7
DOIs
Publication statusPublished - 21 Jun 2023

Bibliographical note

Copyright the Author(s) 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • quetiapine
  • human serum albumin
  • nanoparticles
  • brain targeting
  • antipsychotic activity

Fingerprint

Dive into the research topics of 'Quetiapine albumin nanoparticles as an efficacious platform for brain deposition and potentially improved antipsychotic activity'. Together they form a unique fingerprint.

Cite this